Cargando…

Genomic instability as a major mechanism for acquired resistance to EGFR tyrosine kinase inhibitors in cancer

Detalles Bibliográficos
Autores principales: Liu, Bing, Duenas, Daniela, Zheng, Li, Reckamp, Karen, Shen, Binghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Higher Education Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783936/
https://www.ncbi.nlm.nih.gov/pubmed/34319535
http://dx.doi.org/10.1007/s13238-021-00855-6
_version_ 1784638640484253696
author Liu, Bing
Duenas, Daniela
Zheng, Li
Reckamp, Karen
Shen, Binghui
author_facet Liu, Bing
Duenas, Daniela
Zheng, Li
Reckamp, Karen
Shen, Binghui
author_sort Liu, Bing
collection PubMed
description
format Online
Article
Text
id pubmed-8783936
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Higher Education Press
record_format MEDLINE/PubMed
spelling pubmed-87839362022-02-02 Genomic instability as a major mechanism for acquired resistance to EGFR tyrosine kinase inhibitors in cancer Liu, Bing Duenas, Daniela Zheng, Li Reckamp, Karen Shen, Binghui Protein Cell Commentary Higher Education Press 2021-07-28 2022-02 /pmc/articles/PMC8783936/ /pubmed/34319535 http://dx.doi.org/10.1007/s13238-021-00855-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Commentary
Liu, Bing
Duenas, Daniela
Zheng, Li
Reckamp, Karen
Shen, Binghui
Genomic instability as a major mechanism for acquired resistance to EGFR tyrosine kinase inhibitors in cancer
title Genomic instability as a major mechanism for acquired resistance to EGFR tyrosine kinase inhibitors in cancer
title_full Genomic instability as a major mechanism for acquired resistance to EGFR tyrosine kinase inhibitors in cancer
title_fullStr Genomic instability as a major mechanism for acquired resistance to EGFR tyrosine kinase inhibitors in cancer
title_full_unstemmed Genomic instability as a major mechanism for acquired resistance to EGFR tyrosine kinase inhibitors in cancer
title_short Genomic instability as a major mechanism for acquired resistance to EGFR tyrosine kinase inhibitors in cancer
title_sort genomic instability as a major mechanism for acquired resistance to egfr tyrosine kinase inhibitors in cancer
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783936/
https://www.ncbi.nlm.nih.gov/pubmed/34319535
http://dx.doi.org/10.1007/s13238-021-00855-6
work_keys_str_mv AT liubing genomicinstabilityasamajormechanismforacquiredresistancetoegfrtyrosinekinaseinhibitorsincancer
AT duenasdaniela genomicinstabilityasamajormechanismforacquiredresistancetoegfrtyrosinekinaseinhibitorsincancer
AT zhengli genomicinstabilityasamajormechanismforacquiredresistancetoegfrtyrosinekinaseinhibitorsincancer
AT reckampkaren genomicinstabilityasamajormechanismforacquiredresistancetoegfrtyrosinekinaseinhibitorsincancer
AT shenbinghui genomicinstabilityasamajormechanismforacquiredresistancetoegfrtyrosinekinaseinhibitorsincancer